CAI · Caris Life Sciences, Inc. · Executive Compensation

$23.58 -0.45 (-1.87%)

Russell 1000 member Rebalance outlook locked

Market Cap

$7.18B

282.60M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Dean Halbert	Chief Executive Officer	$764,918	$3,259,311	$15,400,569	—	—	$925,773	$20,350,571
David Spetzler	President	$611,934	$703,725	$2,780,988	$7,472,580	—	$14,000	$11,583,227
J. Russel Denton	Senior Vice President, General Counsel and Secretary	$458,951	$263,897	$2,085,741	$2,532,025	—	$14,000	$5,354,614

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Dean Halbert	Chief Executive Officer	$750,000	$1,500,000	—	—	—	—	$2,250,000
David Spetzler	President	$600,000	$600,000	—	—	—	$13,800	$1,213,800

Key facts CIK 2019410 CUSIP 142152107 13F (30d) 151 filings 151 filers Visit website Investor relations